🇺🇸 FDA
Pipeline program

BXD treatment

CMUH113-REC2-034

Unknown small_molecule completed

Quick answer

BXD treatment for IBD - Inflammatory Bowel Disease is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
IBD - Inflammatory Bowel Disease
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials